[1] |
Xiao N, Li SZ, Qian MB, et al. Contribution of NIPD-CTDR to the parasitic diseases control and elimination in China: memory of the 70th anniversary for NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 401-427.
|
[2] |
Lv S Xu J, Cao CL, et al. China fighting against schistosomiasis for 70 years: progress and experience[J]. Chin J Parasitol Parasit Dis, 2019, 37(5): 514-519. (in Chinese)
|
|
(吕山, 许静, 曹淳力, 等. 我国血吸虫病防治70年历程与经验[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(5): 514-519.)
doi: 10.12140/j.issn.1000-7423.2019.05.002
|
[3] |
Chen JH, Fen J, Zhou XN. From 30 million to zero malaria cases in China: lessons learned for China-Africa collaboration in malaria elimination[J]. Infect Dis Poverty, 2021, 10: 51.
doi: 10.1186/s40249-021-00839-y
|
[4] |
Sun DJ, Fang Y, Huang Y, et al. Contributions to the lymphatic filariasis elimination programme and post-elimination surveillance in China by NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 145-183.
|
[5] |
Feng J, Zhang L, Tu H, et al. From elimination to post-elimination: characteristics, challenges and re-transmission preventing strategy of imported malaria in China.[J]. Chin Trop Med, 2021, 21(1): 5-10. (in Chinese)
doi: 10.13604/j.cnki.46-1064/r.2021.01.02
|
|
(丰俊, 张丽, 涂宏, 等. 从消除到消除后: 中国输入性疟疾的疫情特征、挑战及防止再传播策略[J]. 中国热带医学. 2021, 21(1): 5-10.)
doi: 10.13604/j.cnki.46-1064/r.2021.01.02
|
[6] |
Zhang LJ, Li SZ, Li YL, et al. Interpretation of work plan for pilot counties to promote the elimination of schistosomiasis(2023 edition)[J]. J Trop Dis Parasitol, 2023, 21(3): 121-125. (in Chinese)
|
|
张利娟, 李仕祯, 李银龙, 等. 《血吸虫病消除推进试点县工作方案(2023年版)》解读[J]. 热带病与寄生虫学, 2023, 21(3): 121-125.)
|
[7] |
Fu MH, Han S, Xue CZ, et al. Contribution to the echinococcosis control programme in China by NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 107-144.
|
[8] |
Luo ZW, Zhou ZB, Gong YF, et al. Current status and challenges of visceral leishmaniasis in China[J]. Chin J Parasitol Parasit Dis, 2022, 40(2): 146-152. (in Chinese)
|
|
(罗卓韦, 周正斌, 公衍峰, 等. 我国内脏利什曼病的流行现状和防控挑战[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 146-152.)
doi: 10.12140/j.issn.1000-7423.2022.02.003
|
[9] |
Chen YD, Huang JL, Zhu HH, et al. China’s control process of soil-transmitted helminth infections from pandemic to low-endemic levels[J]. Chin J Parasitol Parasit Dis, 2019, 37(4): 395-398. (in Chinese)
|
|
(陈颖丹, 黄继磊, 朱慧慧, 等. 我国土源性线虫从高感染到低感染水平的防治历程[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(4): 395-398.)
doi: 10.12140/j.issn.1000-7423.2019.04.004
|
[10] |
Wang LY, Qin M, Gavotte L, et al. Societal drivers of human echinococcosis in China[J]. Parasit Vectors, 2022, 15(1): 385.
doi: 10.1186/s13071-022-05480-8
|
[11] |
Wang LD. Opportunities and challenges of “healthy China 2030”[J]. Sci Technol Rev, 2018, 36(22): 8-11. (in Chinese)
|
|
(王陇德. “健康中国2030”的机遇与挑战[J]. 科技导报, 2018, 36(22): 8-11.)
|
[12] |
National Health Commission. China health statistical yearbook 2022[M]. Beijing: Peking Union Medical College Press, 2022: 1-2. (in Chinese)
|
|
(国家卫生健康委员会. 《2022中国卫生健康统计年鉴》[M]. 北京: 中国协和医科大学出版社, 2022: 1-2.)
|
[13] |
Sun DJY, Li LM. Summary and recommendations of development of public health and disease prevention and control[J]. Bull Chin Acade of Sci, 2020, 35(9): 1096-1104. (in Chinese)
|
|
(孙点剑一, 李立明. 浅谈公共卫生与疾病预防控制体系建设[J]. 中国科学院院刊, 2020, 35(9): 1096-104.)
|
[14] |
Gao ZM. On the leading role of public health and preventive medicine in the construction of Healthy China[J]. J Public Heath Prev Med, 2019, 30(5): 5-10. (in Chinese)
|
|
(高忠明. 公共卫生与预防医学在健康中国建设中的引领作用[J]. 公共卫生与预防医学, 2019, 30(5): 5-10.)
|
[15] |
Liu X, Wang L, Chen YF, et al. Thoughts on the reform of disease prevention and control system in China[J]. Chin J Public Heath Manag, 2020, 36(2): 145-148. (in Chinese)
|
|
(刘霞, 王岚, 陈毅峰, 等. 中国疾病预防控制体系改革的思考[J]. 中国公共卫生管理, 2020, 36(2): 145-148.)
|
[16] |
Wu F, Chen Y, Fu C, et al. Key issues and recommendations on restructuring China’s disease control and prevention system[J]. Chin Heath Resour, 2020, 23(3): 185-190, 294. (in Chinese)
|
|
(吴凡, 陈勇, 付晨, 等. 中国疾病预防控制体系发展改革的若干问题与对策建议[J]. 中国卫生资源, 2020, 23(3): 185-190, 294.)
|
[17] |
Wu QWQ, Huang LY, Liu Y, et al. Present situation and suggestions on the construction of talent team in disease prevention and control institutions in China[J]. Chin J Public Heath Manag, 2021, 37(2): 165-168. (in Chinese)
|
|
(吴琼文倩, 黄烈雨, 刘杨, 等. 中国疾病预防控制机构人才队伍建设现状及建议[J]. 中国公共卫生管理, 2021, 37(2): 165-168.)
|
[18] |
Liu CH, Yue YT, Wang YK. Exploration and thoughts on the capacity construction of provincial disease control and prevention institutions in the new era: a case study in Henan Center for Disease Control and Prevention[J]. Mod Dis Contr Prev, 2023, 34(6): 448-451. (in Chinese)
|
|
(刘翠华, 岳义田, 王艺康. 新时代省级疾控机构能力建设的思考: 以河南省疾病预防控制中心为例[J]. 现代疾病预防控制, 2023, 34(6): 448-451.)
|
[19] |
Xu J, Cao CL, Lü S, et al. Schistosomiasis control in China from 2012 to 2021: progress and challenges[J]. Chin J Schisto Control, 2022, 34(6): 559-565, 579. (in Chinese)
|
|
(许静, 曹淳力, 吕山, 等. 血吸虫病防治这10年: 进展与挑战[J]. 中国血吸虫病防治杂志, 2022, 34(6): 559-565, 579.)
|
[20] |
Liu NN, Huang LY, Liu Y, et al. Analysis of the personnel outflow in Chinese center for disease control and prevention from 2014 to 2021[J]. Chin Heath Serv Manag, 2023, 40(4): 289-291, 296. (in Chinese)
|
|
(刘娜娜, 黄烈雨, 刘杨, 等. 2014—2021年中国疾病预防控制中心人员流出情况分析[J]. 中国卫生事业管理, 2023, 40(4): 289-291, 296.)
|
[21] |
Kui Y, Cao CL, Tian S, et al. Evaluation on human resource allocation in certain national institute of parasitic diseases in ten years[J]. Chin J Schisto Control, 2017, 29(2): 197-201. (in Chinese)
|
|
(蒉嫣, 曹淳力, 田申, 等. 我国国家级寄生虫病预防控制机构人才队伍十年发展评价[J]. 中国血吸虫病防治杂志, 2017, 29(2): 197-201.)
|
[22] |
Yin JH, Li M, Yan H, et al. Laboratory diagnosis for malaria in the elimination phase in China: efforts and challenges[J]. Front Med, 2022, 16(1): 10-16.
doi: 10.1007/s11684-021-0889-7
|
[23] |
Qin ZQ, Xu J, Feng T, et al. Strategic thinking of the construction of national schistosomiasis laboratory network in China[J]. Chin J Schisto Control, 2013, 25(4): 329-332. (in Chinese)
|
|
(秦志强, 许静, 冯婷, 等. 全国血吸虫病诊断网络平台建设及思考[J]. 中国血吸虫病防治杂志, 2013, 25(4): 329-332.)
|
[24] |
Wang Q, Xu J, Hao YW, et al. Assessment on the diagnostic capacity for parasitic diseases of health facilities: China, 2019[J]. China CDC Wkly, 2021, 3(35): 731-735.
|
[25] |
Xu J, Li SZ, Guo JG, et al. The WHO new guideline to control and eliminate human schistosomiasis: implications for the verification of transmission interruption and surveillance of Schistosoma japonicum in China[J]. Infect Dis Poverty, 2022, 11(1): 79.
doi: 10.1186/s40249-022-01003-w
|
[26] |
Chen JX, Cai YC, Ai L, et al. Epidemic status and challenges of important human parasitic diseases in China[J]. Lab Med, 2021, 36(10): 993-1000. (in Chinese)
doi: 10.3969/j.issn.1673-8640.2021.010.001
|
|
(陈家旭, 蔡玉春, 艾琳, 等. 我国重要人体寄生虫病防控现状与挑战[J]. 检验医学, 2021, 36(10): 993-1000.)
doi: 10.3969/j.issn.1673-8640.2021.010.001
|
[27] |
Casulli A. New global targets for NTDs in the WHO roadmap 2021—2030[J]. PLoS Negl Trop Dis, 2021, 15(5): e0009373.
|
[28] |
Engels D, Zhou XN. Neglected tropical diseases: an effective global response to local poverty-related disease priorities[J]. Infect Dis Poverty, 2020, 9: 10.
doi: 10.1186/s40249-020-0630-9
pmid: 31987053
|
[29] |
Gong YF, Li YL, Zhang LJ, et al. The potential distribution prediction of Oncomelania hupensis based on newly emerging and reemergent habitats: China, 2015—2019[J]. China CDC Wkly, 2021, 3(5): 90-93.
|
[30] |
Hao YW, Hu XK, Gong YF, et al. Spatio-temporal clustering of mountain-type zoonotic visceral leishmaniasis in China between 2015 and 2019[J]. PLoS Negl Trop Dis, 2021, 15(3): e0009152.
|
[31] |
Zhu HH, Huang JL, Zhou CH, et al. Soil-transmitted helminthiasis in Chinese mainland from 2016 to 2020: a population-based study[J]. Lancet Reg Health West Pac, 2023, 36: 100766.
|
[32] |
Hao YW, Luo ZW, Zhao JA, et al. Transmission risk prediction and evaluation of mountain-type zoonotic visceral leishmaniasis in China based on climatic and environmental variables[J]. Atmosphere, 2022, 13(6): 964.
doi: 10.3390/atmos13060964
|